AU2016903804A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents

Compositions for the treatment of hypertension and/or fibrosis

Info

Publication number
AU2016903804A0
AU2016903804A0 AU2016903804A AU2016903804A AU2016903804A0 AU 2016903804 A0 AU2016903804 A0 AU 2016903804A0 AU 2016903804 A AU2016903804 A AU 2016903804A AU 2016903804 A AU2016903804 A AU 2016903804A AU 2016903804 A0 AU2016903804 A0 AU 2016903804A0
Authority
AU
Australia
Prior art keywords
fibrosis
hypertension
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016903804A
Inventor
Karen Annette Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Ltd
Original Assignee
Vectus Biosystems Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Ltd filed Critical Vectus Biosystems Ltd
Publication of AU2016903804A0 publication Critical patent/AU2016903804A0/en
Priority to CN201780070398.8A priority Critical patent/CN110234631B/en
Priority to RU2019110126A priority patent/RU2752088C1/en
Priority to ES17851990T priority patent/ES2890924T3/en
Priority to JP2019515792A priority patent/JP7177495B2/en
Priority to BR112019005297A priority patent/BR112019005297A2/en
Priority to DK19212378.4T priority patent/DK3640243T3/en
Priority to NZ752196A priority patent/NZ752196A/en
Priority to KR1020197011256A priority patent/KR102640385B1/en
Priority to PCT/AU2017/051027 priority patent/WO2018053588A1/en
Priority to US16/334,283 priority patent/US11053202B2/en
Priority to AU2017329111A priority patent/AU2017329111B9/en
Priority to EP17851990.6A priority patent/EP3515895B1/en
Priority to CA3037222A priority patent/CA3037222C/en
Priority to DK17851990.6T priority patent/DK3515895T3/en
Priority to ES19212378T priority patent/ES2884945T3/en
Priority to EP19212378.4A priority patent/EP3640243B1/en
Priority to CA3223869A priority patent/CA3223869A1/en
Priority to IL265242A priority patent/IL265242B/en
Priority to US17/315,969 priority patent/US11834417B2/en
Priority to JP2022177436A priority patent/JP7381136B2/en
Abandoned legal-status Critical Current

Links

AU2016903804A 2016-09-21 2016-09-21 Compositions for the treatment of hypertension and/or fibrosis Abandoned AU2016903804A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
CA3223869A CA3223869A1 (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2017/051027 WO2018053588A1 (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
EP17851990.6A EP3515895B1 (en) 2016-09-21 2017-09-21 Imidazole derivatives for the treatment of hypertension and/or fibrosis
ES17851990T ES2890924T3 (en) 2016-09-21 2017-09-21 Imidazole derivatives for the treatment of hypertension and/or fibrosis
JP2019515792A JP7177495B2 (en) 2016-09-21 2017-09-21 Compositions for treating hypertension and/or fibrosis
BR112019005297A BR112019005297A2 (en) 2016-09-21 2017-09-21 compound, pharmaceutical composition, and methods for treating hypertension or prehypertension and fibrosis.
DK19212378.4T DK3640243T3 (en) 2016-09-21 2017-09-21 PIPERAZINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION AND / OR FIBROSE
NZ752196A NZ752196A (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
KR1020197011256A KR102640385B1 (en) 2016-09-21 2017-09-21 Composition for treating hypertension and/or pulmonary fibrosis
CN201780070398.8A CN110234631B (en) 2016-09-21 2017-09-21 Composition for treating hypertension and/or fibrosis
US16/334,283 US11053202B2 (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
AU2017329111A AU2017329111B9 (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
RU2019110126A RU2752088C1 (en) 2016-09-21 2017-09-21 Compositions for treatment of hypertension and/or fibrosis
CA3037222A CA3037222C (en) 2016-09-21 2017-09-21 Compositions for the treatment of hypertension and/or fibrosis
DK17851990.6T DK3515895T3 (en) 2016-09-21 2017-09-21 IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION AND / OR FIBROSE
ES19212378T ES2884945T3 (en) 2016-09-21 2017-09-21 Piperazine derivatives for the treatment of hypertension and / or fibrosis
EP19212378.4A EP3640243B1 (en) 2016-09-21 2017-09-21 Piperazine derivatives for the treatment of hypertension and/or fibrosis
IL265242A IL265242B (en) 2016-09-21 2019-03-07 Compositions for the treatment of hypertension and/or fibrosis
US17/315,969 US11834417B2 (en) 2016-09-21 2021-05-10 Compositions for the treatment of hypertension and/or fibrosis
JP2022177436A JP7381136B2 (en) 2016-09-21 2022-11-04 Composition for treating hypertension and/or fibrosis

Publications (1)

Publication Number Publication Date
AU2016903804A0 true AU2016903804A0 (en) 2016-10-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3347469A4 (en) Methods and compositions for the treatment of glaucoma
EP3423100A4 (en) Compositions for treating inflammation and methods of treating the same
EP3634426A4 (en) Compositions for the treatment of fibrosis
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3651801A4 (en) Compositions and methods for the treatment of fungal infections
TWI799397B (en) Compositions for the treatment of hypertension
EP3573620A4 (en) Compositions for the treatment of hypertension
EP3303366A4 (en) Derivatives of dolastatin 10 and uses thereof
EP3310783A4 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
EP3522873A4 (en) Compositions and methods for the treatment of xerostomia
EP3046902A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3226873A4 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
EP3724293A4 (en) Asphalt compositions and methods of using the same
EP3046901A4 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3463347A4 (en) Triazole benzamide derivatives and the compositions and methods of treatment regarding the same
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
EP3706767A4 (en) Compositions and methods for the treatment of allergy
EP3694517A4 (en) Compositions and methods for treatment of fibrosis
EP3490584A4 (en) Methods and compositions for the treatment of melanoma
EP3500274A4 (en) Methods and compositions for the treatment of warts
IL265242B (en) Compositions for the treatment of hypertension and/or fibrosis
EP3703691A4 (en) Pharmaceutical compositions for controlling and/or reducing the progression of myopia
EP3490970A4 (en) Compositions for the treatment of pulmonary fibrosis
EP3554494A4 (en) Compositions and methods for the treatment of inflammation